|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Jamal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun M: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar
|
|
3
|
Macdonald JS, Smalley SR, Benedetti J, et
al: Chemoradiotherapy after surgery compared with surgery alone for
adenocarcinoma of the stomach or gastroesophageal junction. N Engl
J Med. 345:725–730. 2001. View Article : Google Scholar
|
|
4
|
Mackenzie M, Spithoff K and Jonker D:
Systemic therapy for advanced gastric cancer: a clinical practice
guideline. Curr Oncol. 18:e202–e209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shekhar MP: Drug resistance: challenges to
effective therapy. Curr Cancer Drug Targets. 11:613–623. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pasini F, Fraccon AP and DE Manzoni G: The
role of chemotherapy in metastatic gastric cancer. Anticancer Res.
31:3543–3554. 2011.PubMed/NCBI
|
|
7
|
Qian L, Xu Z, Zhang W, Wilson B, Hong JS
and Flood PM: Sinomenine, a natural dextrorotatory morphinan
analog, is anti-inflammatory and neuroprotective through inhibition
of microglial NADPH oxidase. J Neuroinflammation. 4:23–37. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Q and Li XK: Immunosuppressive and
anti-inflammatory activities of sinomenine. Int Immunopharmacol.
11:373–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Yue PY, Ha WY, et al: Effect of
sinomenine on gene expression of the IL-1 beta-activated human
synovial sarcoma. Life Sci. 79:665–673. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang T, Zhou L, Zhang W, Qu D, Xu X, Yang
Y and Li S: Effects of sinomenine on proliferation and apoptosis in
human lung cancer cell line NCI-H460 in vitro. Mol Med Report.
3:51–56. 2010.PubMed/NCBI
|
|
11
|
Zhou L, Luan H, Liu Q, Jiang T, Liang H,
Dong X and Shang H: Activation of PI3K/Akt and ERK signaling
pathways antagonized sinomenine-induced lung cancer cell apoptosis.
Mol Med Report. 5:1256–1260. 2012.PubMed/NCBI
|
|
12
|
Hong Y, Yang J, Shen X, et al: Sinomenine
hydrochloride enhancement of the inhibitory effects of
anti-transferrin receptor antibody-dependent on the COX-2 pathway
in human hepatoma cells. Cancer Immunol Immunother. 62:447–454.
2013. View Article : Google Scholar
|
|
13
|
Lv Y, Li C, Li S and Hao Z: Sinomenine
inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via
suppression of cyclooxygenase-2 expression. Oncol Lett. 2:741–745.
2011.PubMed/NCBI
|
|
14
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chou TC, Motzer RJ, Tong Y and Bosl GJ:
Computerized quantitation of synergism and antagonism of taxol,
topotecan, and cisplatin against human teratocarcinoma cell growth:
a rational approach to clinical protocol design. J Natl Cancer
Inst. 86:1517–1524. 1994. View Article : Google Scholar
|
|
16
|
Dikken JL, van de Velde CJ, Coit DG, Shah
MA, Verheij M and Cats A: Treatment of resectable gastric cancer.
Therap Adv Gastroenterol. 5:49–69. 2012. View Article : Google Scholar
|
|
17
|
Tsutani Y, Yoshida K, Sanada Y, et al:
Decreased orotate phosphoribosyltransferase activity produces
5-fluorouracil resistance in a human gastric cancer cell line.
Oncol Rep. 20:1545–1551. 2008.
|
|
18
|
Meyer HJ and Wilke H: Treatment strategies
in gastric cancer. Dtsch Arztebl Int. 108:698–705. 2011.PubMed/NCBI
|
|
19
|
Liu L, Buchner E, Beitze D, Schmidt-Weber
CB, et al: Amelioration of rat experimental arthritides by
treatment with the alkaloid sinomenine. Int J Immunopharmacol.
18:529–543. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu B, Zeng Y, Yin C, Wang H, Yang X, Wang
S and Ji X: Sinomenine reduces iNOS expression via inhibiting the
T-bet IFN-γ pathway in experimental autoimmune encephalomyelitis in
rats. J Biomed Res. 26:448–455. 2012.PubMed/NCBI
|
|
21
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Nijhawan D, Budihardjo I,
Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and
dATP-dependent formation of Apaf-1/caspase-9 complex initiates an
apoptotic protease cascade. Cell. 91:479–489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J, Liu X, Bhalla K, et al: Prevention
of apoptosis by Bcl-2: release of cytochrome c from mitochondria
blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slee EA, Harte MT, Kluck RM, et al:
Ordering the cytochrome c-initiated caspase cascade: hierarchical
activation of caspases-2,-3,-6,-7,-8, and-10 in a
caspase-9-dependent manner. J Cell Biol. 144:281–292. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spears CP, Shahinian AH, Moran RG,
Heidelberger C and Corbett TH: In vivo kinetics of
thymidylatesynthetase inhibition of 5-fluorouracil-sensitive and
-resistant murine gastric adenocarcinomas. Cancer Res. 42:450–456.
1982.PubMed/NCBI
|
|
26
|
Kitchens ME, Forsthoefel AM, Barbour KW,
Spencer HT and Berger FG: Mechanisms of acquired resistance to
thymidylate synthase inhibitors: the role of enzyme stability. Mol
Pharmacol. 56:1063–1070. 1999.PubMed/NCBI
|
|
27
|
Kirihara Y, Yamamoto W, Toge T and
Nishiyama M: Dihydropyrimidine dehydrogenase, multidrug
resistance-associated protein, and thymidylate synthase gene
expression levels can predict 5-fluorouracil resistance in human
gastrointestinal cancer cells. Int J Oncol. 14:551–556. 1999.
|
|
28
|
Peters G, Van der Wilt C, Van Triest B, et
al: Thymidylate synthase and drug resistance. Eur J Cancer.
31:1299–1305. 1995. View Article : Google Scholar
|
|
29
|
Goekkurt E, Hoehn S, Wolschke C, Wittmer
C, Stueber C, Hossfeld DK and Stoehlmacher J: Polymorphisms of
glutathione S-transferases (GST) and thymidylate synthase (TS) -
novel predictors for response and survival in gastric cancer
patients. Br J Cancer. 94:281–286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnston PG, Lenz HJ, Leichman CG,
Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate
synthase gene and protein expression correlate and are associated
with response to 5-fluorouracil in human colorectal and gastric
tumors. Cancer Res. 55:1407–1412. 1995.PubMed/NCBI
|
|
31
|
Lenz HJ, Leichman CG, Danenberg KD, et al:
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a
predictor for primary tumor response and overall survival. J Clin
Oncol. 14:176–182. 1996.PubMed/NCBI
|
